| Primary |
| Hiv Infection |
60.9% |
| Drug Exposure During Pregnancy |
9.0% |
| Prophylaxis Against Hiv Infection |
5.0% |
| Antiviral Treatment |
3.2% |
| Maternal Exposure During Pregnancy |
2.9% |
| Human Immunodeficiency Virus Transmission |
2.4% |
| Prophylaxis |
2.3% |
| Exposure During Pregnancy |
2.2% |
| Hypertension |
2.1% |
| Acquired Immunodeficiency Syndrome |
1.7% |
| Antiretroviral Therapy |
1.4% |
| Hiv Test Positive |
1.3% |
| Vertical Infection Transmission |
1.3% |
| Antiviral Prophylaxis |
1.2% |
| Myocardial Ischaemia |
0.8% |
| Retroviral Infection |
0.6% |
| Lymph Node Tuberculosis |
0.5% |
| Depression |
0.4% |
| Pneumocystis Jiroveci Pneumonia |
0.4% |
| Anaemia |
0.4% |
|
| Abortion Spontaneous |
14.5% |
| Rash |
12.6% |
| Stillbirth |
8.9% |
| Stevens-johnson Syndrome |
7.4% |
| Abortion Induced |
6.9% |
| Vomiting |
6.6% |
| Pneumonia |
4.4% |
| Small For Dates Baby |
4.3% |
| Premature Baby |
3.7% |
| Death |
3.5% |
| Sepsis |
3.4% |
| Neutropenia |
3.0% |
| Ventricular Septal Defect |
2.8% |
| Medication Residue |
2.7% |
| Microcephaly |
2.7% |
| Rash Generalised |
2.7% |
| Pyrexia |
2.5% |
| Rash Maculo-papular |
2.5% |
| Thrombocytopenia |
2.5% |
| Viral Load Increased |
2.5% |
|
| Secondary |
| Hiv Infection |
60.4% |
| Drug Exposure During Pregnancy |
6.2% |
| Drug Use For Unknown Indication |
5.0% |
| Product Used For Unknown Indication |
4.7% |
| Antiviral Prophylaxis |
2.9% |
| Prophylaxis Against Hiv Infection |
2.7% |
| Acquired Immunodeficiency Syndrome |
2.6% |
| Antiviral Treatment |
2.1% |
| Human Immunodeficiency Virus Transmission |
2.0% |
| Hypertension |
1.9% |
| Prophylaxis |
1.6% |
| Hiv Test Positive |
1.5% |
| Antiretroviral Therapy |
1.4% |
| Exposure During Pregnancy |
0.9% |
| Haemophilia |
0.9% |
| Retroviral Infection |
0.8% |
| Herpes Simplex |
0.7% |
| Diarrhoea |
0.6% |
| Abdominal Pain |
0.5% |
| Constipation |
0.5% |
|
| Drug Exposure During Pregnancy |
14.0% |
| Stillbirth |
9.1% |
| Stevens-johnson Syndrome |
8.2% |
| Abortion Spontaneous |
7.8% |
| Vomiting |
6.3% |
| Microcephaly |
5.4% |
| Pregnancy |
5.4% |
| Premature Baby |
5.0% |
| Normal Newborn |
4.7% |
| Vitamin B12 Deficiency |
4.3% |
| Myocardial Infarction |
3.9% |
| Osteonecrosis |
3.4% |
| Talipes |
3.2% |
| Neutropenia |
3.0% |
| Umbilical Hernia |
3.0% |
| Pyrexia |
2.8% |
| Toxic Epidermal Necrolysis |
2.8% |
| Peritonitis |
2.6% |
| Rash Maculo-papular |
2.6% |
| Ultrasound Antenatal Screen Abnormal |
2.6% |
|
| Concomitant |
| Hiv Infection |
55.9% |
| Product Used For Unknown Indication |
7.4% |
| Drug Use For Unknown Indication |
6.4% |
| Hypertension |
5.6% |
| Acquired Immunodeficiency Syndrome |
3.2% |
| Ischaemic Cardiomyopathy |
3.1% |
| Depression |
2.5% |
| Hiv Test Positive |
1.8% |
| Antiretroviral Therapy |
1.5% |
| Smoking Cessation Therapy |
1.5% |
| Hypercholesterolaemia |
1.5% |
| Neuralgia |
1.5% |
| Diabetes Mellitus |
1.4% |
| Drug Exposure During Pregnancy |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
| Hepatitis C |
1.0% |
| Pain |
1.0% |
| Antiviral Prophylaxis |
0.9% |
| Thrombosis |
0.9% |
| Hiv Infection Cdc Category C3 |
0.8% |
|
| Somnolence |
11.0% |
| Myocardial Infarction |
9.7% |
| Vomiting |
9.7% |
| Abortion Spontaneous |
5.8% |
| Weight Increased |
5.8% |
| Anaemia |
4.5% |
| Osteonecrosis |
4.5% |
| Pregnancy |
4.5% |
| Respiratory Distress |
4.5% |
| Thrombocytopenia |
4.5% |
| Weight Decreased |
4.5% |
| Cerebrovascular Accident |
3.9% |
| Transaminases Increased |
3.9% |
| Vertigo |
3.9% |
| Nausea |
3.2% |
| Neutropenia |
3.2% |
| Peritonitis |
3.2% |
| Premature Baby |
3.2% |
| Premature Labour |
3.2% |
| Spinal Compression Fracture |
3.2% |
|
| Interacting |
| Hiv Infection |
50.0% |
| Hiv Test Positive |
25.0% |
| Smoking Cessation Therapy |
25.0% |
|
| Rash |
50.0% |
| Urticaria |
50.0% |
|
